Creating a new wound dressing to speed up healing for diabetic patients
Engineering the open porous nanofibrous microsphere integrated fibrillar hydrogel for the co-delivery of antibacterial and angiogenic agents aimed at the rapid diabetic wound repair
['FUNDING_R01'] · TERASAKI INSTITUTE FOR BIOMEDICAL INNOVATION · NIH-10873792
This study is testing a new type of wound dressing made from tiny fibers and a gel that helps diabetic wounds heal faster by keeping them moist and delivering healing ingredients right where they're needed.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | TERASAKI INSTITUTE FOR BIOMEDICAL INNOVATION (nih funded) |
| Locations | 1 site (Woodland Hills, UNITED STATES) |
| Trial ID | NIH-10873792 on ClinicalTrials.gov |
What this research studies
This research focuses on developing an innovative wound dressing made from special nanofibers and a gel that can release healing agents to help diabetic wounds heal faster. The dressing is designed to enhance cell movement and tissue formation, which are crucial for closing wounds effectively. By using advanced techniques to create a porous structure, the dressing aims to provide a moist environment and deliver antibacterial and angiogenic agents directly to the wound site. This approach could significantly improve the healing process for patients with diabetic wounds.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with diabetic wounds that are slow to heal or at risk of infection.
Not a fit: Patients with non-diabetic wounds or those who do not have chronic wound healing issues may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to faster and more effective healing of diabetic wounds, reducing the risk of complications such as infections and amputations.
How similar studies have performed: Previous research has shown promising results with similar approaches using nanofibrous scaffolds for wound healing, indicating potential for success in this novel application.
Where this research is happening
Woodland Hills, UNITED STATES
- TERASAKI INSTITUTE FOR BIOMEDICAL INNOVATION — Woodland Hills, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: VITHARIKUNNIL JOHN, JOHNSON — TERASAKI INSTITUTE FOR BIOMEDICAL INNOVATION
- Study coordinator: VITHARIKUNNIL JOHN, JOHNSON
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Bacterial Infections